Genomic Health (Nasdaq: GHDX) announced positive results from a liquid biopsy proof-of-concept study demonstrating its ability to more conveniently detect ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE